We are a

Global
Medical Device accelerator

We are focused on developing innovative solutions to serve large unmet clinical needs.

About us

NuXcel is a global medical device accelerator focused on developing innovative solutions to serve large unmet clinical needs.  Mudit K. Jain, PhD., Founder and General Partner of Strategic Healthcare Investment Partners (S.H.I.P), and previously with Synergy Life Science Partners, and Lynn Elliott, a serial entrepreneur and seasoned medical device leader, previously with Spinal Modulation and Guidant/Boston Scientific established NuXcel in 2018.

Smart Devices

Our core strength lies in electrically active, smart devices that can sense and treat multiple acute and chronic conditions.

Lean Innovation Model

NuXcel is based on a lean innovation model and works with trusted partners across the medical device ecosystem leveraging nearly 50 years of cumulative relationships in that ecosystem.

Global

With locations in Ireland, Minneapolis, and Silicon Valley, we are truly global in our reach and approach.

Meet the Team

NuXcel is led by medical device veterans who have brought multiple novel medical technologies to the market and helped create world class companies.

Mudit K. Jain

Mudit K. Jain

Founder and CEO

Mudit brings two decades of entrepreneurial experiences in medical device industry across R&D, business development, company formation, venture capital, and a global perspective to healthcare based on his experiences in USA, Ireland, and India. Mudit has a unique blend of experiences as a private venture capitalist at Synergy Life Science Partners, and as a strategic investor with Johnson and Johnson Development Corporation (JJDC). Mudit serves on boards of Neurotronik, Ltd., Inspire Medical Systems (NYSE: INSP), Noctrix, Ltd., NuXcel, Ltd. And ShiraTronics, Inc.  Most recently, as a General Partner with Synergy Life Science Partners, Mudit delivered top quartile performance.

Earlier in his career, Mudit held operational roles at Guidant Corporation’s Cardiac Rhythm Management Division and in petrochemical industry in India. Mudit played an important role in product  development for start-ups like Epicor, Inc. (acquired: St. Jude Medical), and Cardiac Pathways Corporation (acquired: Boston Scientific). Mudit holds eight issued patents and has published numerous articles in peer reviewed publications.

Mudit currently serves on the Board of Visitors at Duke University’s Graduate School, John Hopkins University Coulter Program Oversight Board, and on the  board of One Heart Health, an organization dedicated to advancing remote monitoring technologies to identify and treat cardiac disease in children across the globe. Mudit also served as Chair of TiE LifeSciences, Silicon Valley from 2012-2014.

Mudit graduated with a B.E. in Electrical Engineering from Regional Engineering College, Nagpur, India (ranked first in his class). He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.

Lynn Elliott

Lynn Elliott

Founder and CTO

Lynn brings three decades of active implantable device experience in medical device innovation, R&D, manufacturing, clinical trials, and regulatory approvals to healthcare challenges. Lynn has a unique blend of experience in large medical device companies such as Guidant and Boston Scientific and small venture capital funded startups like Spinal Modulation, SacraMed, and ShiraTronics.

At Guidant, Lynn held leadership positions in Product Development and Research & Advanced Technologies and was a key driver of delivering pacemakers, implantable defibrillators and cardiac resynchronization device to the global market with revenues in excess $1B.

At Spinal Modulation, Lynn held the position of Chief Technology Officer and was a key driver of defining and delivering an innovative neurostimulation device for the management of chronic pain. Spinal Modulation was acquired by St Jude (Abbott) in a deal valued in excess of $500M.

Lynn holds over 20 US patents and has published numerous articles in peer reviewed publications.  Lynn graduated with a BS in Electrical Engineering from South Dakota School of Mines and Technology, an MS in Software Engineering from St Thomas University and advanced studies in Software Engineering at the University of Minnesota.

Representative companies we have been involved with

What we look for

Our selection criteria for projects is based on following filters:

Large unmet clinical need with motivated patient group seeking therapy

Strong proof of concept of underlying therapy

Existing or emerging reimbursement

Capital efficient development plan with lean innovation drivers as a value builder for all stakeholders

Strong and domain experienced team

PORTFOLIO

ShiraTronics is the first spin off company from NuXcel. ShiraTronics is focused on treating chronic medical conditions utilizing novel neuromodulation technologies. ShiraTronics is based in Minneapolis and Ireland.

www.shiratronics.com

Let’s Start Something new
Say Hello!